Back
Monopar Therapeutics Stock Price Chart
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Buy
73
MNPR
Monopar Therapeutics
Last Price:
$28.72
Seasonality Move:
-15.33%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.83 | Buy |
| 20-day SMA: | 25.18 | Buy |
| 50-day SMA: | 22.21 | Buy |
| 200-day SMA: | 8.79 | Buy |
| 8-day EMA: | 26.36 | Buy |
| 20-day EMA: | 24.97 | Buy |
| 50-day EMA: | 21.59 | Buy |
| 200-day EMA: | 11.81 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 66.29 | Buy |
| Chaikin Money Flow: | 31078 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.75 - 27.41) | Buy |
| Bollinger Bands (100): | (4.9 - 23.48) | Buy |
Monopar Therapeutics Technical Analysis
| Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 30.48 while MNPR 8-day simple moving average is 25.83, which is a Buy signal.
-
The stock price of MNPR is 30.48 while Monopar Therapeutics 20-day SMA is 25.18, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 22.21 while MNPR share price is 30.48, making it a Buy technically.
-
MNPR stock price is 30.48 and Monopar Therapeutics 200-day simple moving average is 8.79, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
73
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a BuyThe current Monopar Therapeutics [MNPR] share price is $30.48. The Score for MNPR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
160.9M
Price in USD:
30.48
Share Volume:
63.8K
Monopar Therapeutics 52-Week Range
52-Week High:
38.50
52-Week Low:
1.55
Buy
73
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 30.48 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 30.48 while MNPR 8-day exponential moving average is 26.36, which is a Buy signal.
-
The stock price of MNPR is 30.48 while Monopar Therapeutics 20-day EMA is 24.97, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 21.59 while MNPR share price is 30.48, making it a Buy technically.
-
MNPR stock price is 30.48 and Monopar Therapeutics 200-day simple moving average is 11.81, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $2.12 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is 1.37, suggesting Monopar Therapeutics is a Buy
-
Monopar Therapeutics Relative Strength Index (RSI) is 66.29, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (22.75 - 27.41), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (4.9 - 23.48), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.